GNSRX Mutual Fund

GNSRX Mutual Fund

NAV$38.25
See how much of GNSRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 58 holdings · as of Sep 30, 2026
Top 10 weight
26.48%
GNSRX top 10 holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LGND
Ligand Pharmaceuticals, Inc.Health Care · Biotechnology
2.89%
2.9%33,348$10.42MHealth CareBiotechnology
2
QTWO
Q2 Holdings, Inc.Info Tech · Software
2.80%
5.7%182,357$10.11MInfo TechSoftware
Sector and industry · Pro
3—Kiniksa Pharmaceuticals Inte
2.80%
8.5%135,243$10.09M
4
MGY
Magnolia Oil & Gas Corp
2.78%
11.3%427,280$10.04M
5
WTFC
Wintrust Financial Corp
2.68%
13.9%68,052$9.65M
6
ANIP
Ani Pharmaceuticals Inc
2.67%
16.6%132,740$9.64M
7
WSFS
Wsfs Financial Corp
2.51%
19.1%119,832$9.06M
8
SBCF
Seacoast Banking Corp Of Florida
2.48%
21.6%280,655$8.93M
9
SUPN
Supernus Pharmaceuticals Inc
2.48%
24.1%207,388$8.93M
10
ABCB
Ameris Bancorp
2.39%
26.5%108,553$8.63M
More holdings · Pro
FundXLS Pro
See the other 48 holdings of GNSRX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
BiotechnologyPharmaceuticalsDigital BankingLending & CreditInvestment TechnologyCloud ComputingData & AnalyticsEnergy SecurityInflation ProtectionGlobal BankingInterest RatesSocial ImpactPaymentsHealth & Wellness

GNSRX Mutual Fund Top Holdings

GNSRX holdings top 10 positions. The top 10 holdings account for 26.5% of the fund, led by Ligand Pharmaceuticals, Inc. at 2.9%, Q2 Holdings, Inc. at 2.8%, Kiniksa Pharmaceuticals Inte at 2.8%.

GNSRX portfolio concentration is well-diversified, with the top 10 representing 26.5% of total assets. The largest sector exposure is Financials at 20.5%.

GNSRX sectors provide a detailed breakdown. GNSRX overlap shows how holdings compare to other funds in your portfolio.